There is no single “best” hospital for pancreatic cancer, but the hospitals that consistently produce the best outcomes share specific qualities: high surgical volume, NCI designation, multidisciplinary teams, and active clinical trial programs. The most important factor backed by data is how many pancreatic surgeries a center performs each year. Patients treated at the highest-volume centers are roughly three times less likely to die from surgery than those at low-volume hospitals.
Why Surgical Volume Matters More Than Reputation
Pancreatic surgery is among the most complex operations in medicine. The Whipple procedure, which removes the head of the pancreas along with parts of the small intestine, bile duct, and sometimes the stomach, carries real risk even in expert hands. But that risk varies dramatically depending on where you have it done.
A study published in the Annals of Surgery found that hospitals performing fewer than five pancreatic resections per year had an in-hospital mortality rate of 9.2%. Medium-volume centers (5 to 18 per year) had a rate of 5.9%. The highest-volume centers, doing more than 18 resections annually, had a mortality rate of just 2.5%. For the Whipple procedure specifically, the gap was even wider: 11.1% mortality at the lowest-volume hospitals compared to 2.7% at the highest-volume ones.
This isn’t just about the surgeon’s skill. High-volume centers have specialized anesthesiologists, intensive care teams, interventional radiologists, and nurses who manage post-surgical complications daily. When something goes wrong after a Whipple, the speed and expertise of the response often determines whether a patient survives.
Top-Ranked Hospitals for GI Cancer Surgery
U.S. News & World Report ranks hospitals for gastroenterology and GI surgery, which is the category most relevant to pancreatic cancer treatment. The 2024-2025 top 10 are:
- Mayo Clinic (Rochester, MN) — Score: 100/100
- Cedars-Sinai Medical Center (Los Angeles, CA) — 92.5
- Cleveland Clinic (Cleveland, OH) — 90.4
- NYU Langone Hospitals (New York, NY) — 90.1
- Mount Sinai Hospital (New York, NY) — 89.5
- Johns Hopkins Hospital (Baltimore, MD) — 88.1
- Houston Methodist Hospital (Houston, TX) — 87.8
- UCLA Medical Center (Los Angeles, CA) — 86.9
- Massachusetts General Hospital (Boston, MA) — 86.0
- Northwestern Memorial Hospital (Chicago, IL) — 85.1
These rankings reflect overall GI expertise, not pancreatic cancer specifically. Several other hospitals that don’t top this particular list have world-class pancreatic cancer programs, including MD Anderson Cancer Center in Houston and Memorial Sloan Kettering in New York.
Hospitals With Standout Pancreatic Cancer Programs
Johns Hopkins Hospital
Johns Hopkins has performed over 5,000 Whipple procedures, more than any other institution in the world. In recent years, the hospital has done close to 300 Whipple surgeries annually with a mortality rate under 1%, well below the national average. Johns Hopkins essentially pioneered the modern approach to pancreatic cancer surgery and remains one of the primary training grounds for pancreatic surgeons nationwide.
MD Anderson Cancer Center
MD Anderson in Houston sees approximately 400 pancreatic cancer patients per year and runs dozens of clinical trials simultaneously. A review of their phase I trial program found 95 pancreatic cancer patients enrolled across 52 different clinical trials over a six-year period. If your cancer is advanced or you’re looking for access to experimental therapies, MD Anderson’s trial pipeline is one of the deepest in the country.
Mayo Clinic
Mayo Clinic has published notable research on extending survival for patients whose pancreatic tumors involve major blood vessels, a situation traditionally considered inoperable. In one study of 194 patients who received chemotherapy followed by radiation and surgery, the group with the best response to chemotherapy achieved a median survival of 58.8 months, just under five years. That’s a striking number for a cancer where average survival with advanced disease is typically 12 to 18 months.
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering in New York uses a multidisciplinary team model where surgeons, medical oncologists, radiation oncologists, gastroenterologists, radiologists, and pathologists collaborate on each patient’s diagnosis and treatment plan. Many of their clinicians are also researchers running clinical trials, which gives patients potential access to new therapies before they become widely available.
Cleveland Clinic
Ranked the No. 2 hospital in the world by Newsweek for seven consecutive years, Cleveland Clinic places in the top tier for both gastroenterology and oncology globally. Their gastroenterology program ranks No. 3 nationally per U.S. News.
What Makes a Hospital Right for Pancreatic Cancer
Rankings are a starting point, not the final answer. The best hospital for you depends on your specific situation: whether the tumor is resectable, whether you need chemotherapy first to shrink it, and whether you’re a candidate for clinical trials. Here’s what to prioritize when evaluating a center.
NCI designation. The National Cancer Institute formally recognizes cancer centers that meet rigorous standards for research, treatment, and education. Patients at NCI-designated centers typically get earlier access to new therapies through clinical trials, care from subspecialists who focus exclusively on their cancer type, and higher surgical success rates for complex procedures. There are roughly 70 NCI-designated cancer centers in the U.S., and not all hospitals on the GI surgery rankings carry this designation.
Dedicated pancreatic cancer team. You want a center where surgeons operate on pancreatic tumors regularly, not one where a general surgeon does a Whipple a few times a year. A true multidisciplinary team includes a hepatobiliary or pancreatic surgeon, a medical oncologist who specializes in GI cancers, a radiation oncologist, a gastroenterologist, and specialized pathologists who can accurately stage and characterize the tumor.
Clinical trial availability. Pancreatic cancer has fewer effective standard treatments than many other cancers, which makes clinical trial access especially valuable. The Pancreatic Cancer Action Network coordinates a clinical trial network called Precision Promise with over 20 participating sites across the U.S. Ask any hospital you’re considering how many pancreatic cancer trials they currently have open.
Robotic and minimally invasive surgery options. Some high-volume centers now offer robotic-assisted Whipple procedures, which use smaller incisions and provide the surgeon with better visibility. Patients who have robotic surgery typically experience less blood loss, less pain, faster recovery, and lower risk of wound infection compared to traditional open surgery. Cancer outcomes are comparable to open surgery at experienced centers, with fewer conversions to open procedures than standard laparoscopic approaches. Only a handful of centers worldwide have enough experience to be considered high-volume for robotic pancreatic surgery.
Questions to Ask Before Choosing a Center
When meeting with a surgeon or oncologist for the first time, Johns Hopkins recommends asking directly: How many pancreatic cancer surgeries have you personally performed? What have the outcomes been for your patients? Where were you trained, and which surgeons did you study under? These are not rude questions. Experienced surgeons expect them and will answer without hesitation.
You should also ask how many pancreatic resections the hospital performs annually. If the number is under 15 to 20 per year, the data strongly suggests you’d benefit from seeking care at a higher-volume center, even if it means traveling. The survival difference between low-volume and high-volume hospitals is one of the most consistent findings in surgical research, and for pancreatic cancer, it can be the difference between a 2.5% surgical mortality rate and an 11% one.
If traveling to a major center isn’t realistic for every appointment, many top hospitals now offer remote tumor board reviews. Your local oncologist sends your scans and pathology, and a panel of specialists at the larger center weighs in on your treatment plan. This hybrid approach lets you get expert guidance while receiving day-to-day care closer to home.